EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53

Dita Strachotová, Aleš Holoubek, Kateřina Wolfová, Barbora Brodská iD, Petr Heřman iD

The FEBS Journal · 2023

DOI: 10.1111/febs.16810 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2023. Verfasst von Dita Strachotová und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Mathematics and Physics, Institute of Physics, Charles University, Prague 2, Czech Republic. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Nuclear Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grantová Agentura České Republiky, Ministerstvo Zdravotnictví Ceské Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Specific C‐terminal nucleophosmin (NPM) mutations are related to the acute myeloid leukaemia and cause mistargeting of mutated NPM (NPMmut) to the cytoplasm. Consequently, multiple NPM‐interacting partners, e.g., the tumour suppressor p53, become also mislocalized. We found that ubiquitin ligase Mdm2 mislocalizes to the cytoplasm in the presence of NPMmut as well. Since p53 interacts with Mdm2, we searched for the NPMmut‐p53‐Mdm2 complex and interactions of its constituents in live cells and cell lysates using fluorescently tagged proteins, fluorescence lifetime imaging and immunoprecipitation. We proved existence of the ternary complex, which likely adopts a chain‐like configuration. Interaction between Mdm2 and NPMmut was not detected, even under conditions of upregulated Mdm2 and p53 induced by Actinomycin D. We assume that p53 serves in the complex as a bridging link between Mdm2 and NPMmut. This conclusion was supported by disruption of the Mdm2–p53 interaction by Nutlin‐3A, which resulted in relocalization of Mdm2 to the nucleus, while both NPMmut and p53 remained in the cytoplasm. Importantly, silencing of p53 also prevented mislocalization of Mdm2 in the presence of NPMmut.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Nuclear ProteinsNucleophosminMutationProto-Oncogene Proteins c-mdm2Cytoplasm

Stichwörter der Autor:innen

FRET-FLIMMdm2acute myeloid leukaemianucleophosmin mutationp53

Substanzen

Tumor Suppressor Protein p53Nuclear ProteinsNucleophosminProto-Oncogene Proteins c-mdm2

Autor:innen und Institutionen

  • Faculty of Mathematics and Physics, Institute of Physics, Charles University, Prague 2, Czech Republic.
  • Department of Proteomics, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic.

ORCID-Profile: Barbora Brodská, Petr Heřman

Förderung

  • Grantová Agentura České Republiky
  • Ministerstvo Zdravotnictví Ceské Republiky

Zitieren

APA

Strachotová, D., Holoubek, A., Wolfová, K., Brodská, B., & Heřman, P. (2023). Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53. The FEBS Journal. https://doi.org/10.1111/febs.16810

Vancouver

Strachotová D, Holoubek A, Wolfová K, Brodská B, Heřman P. Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53. The FEBS Journal. 2023. doi:10.1111/febs.16810

BibTeX
@article{Strachotov2023,
  author = {Strachotová, Dita and Holoubek, Aleš and Wolfová, Kateřina and Brodská, Barbora and Heřman, Petr},
  title = {Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53},
  journal = {The FEBS Journal},
  year = {2023},
  doi = {10.1111/febs.16810}
}
Kostenlos starten →